Continuing Medical Education · 4.5 AMA PRA Category 1 Credits™ available
Managing Menopause After Breast Cancer
A half-day, case-based CME program for women's health clinicians, presented by OncoMenopause and the OncoMenopause Consortium®, an education initiative of HERmedicine.
In San Diego — Tuesday morning, before The Menopause Society Annual Meeting begins at 1:00 PM
Tuesday, October 20, 2026
7:00 AM – 12:30 PM · Breakfast included
$275 early-bird · $325 general
Omni San Diego, Hotel at the Ballpark
“Is hormone therapy safe after breast cancer?”
Your patients are asking — and hearing conflicting answers on social media. This program moves beyond the reflexive “no” to give you evidence, nuance, and practical frameworks for the survivors in your practice.
the program
What Does This CME Program Cover?
Managing Menopause After Breast Cancer is a 4.5 AMA PRA Category 1 Credits™ program from OncoMenopause and the OncoMenopause Consortium®, held October 20, 2026, in San Diego. Led by Dr. Lisa Larkin and Dr. Maryam Lustberg, it teaches women's health clinicians how to manage menopause symptoms, contraception, and HSDD (Hypoactive Sexual Desire Disorder) in breast cancer survivors through real clinical cases.
As more women survive breast cancer, clinicians across specialties are being asked to manage menopausal symptoms in patients with a history of hormone-sensitive disease — often without dedicated training to do it confidently.
Built around case panels rather than lecture-only slides, the morning gives attendees a framework they can put to use the next week in clinic.
4.5
AMA PRA Category 1 Credits™
5.5
Hours programming
3
Case panel sessions
2
Program Chairs
COURSE PANEL
Who Is Teaching This Course?
Both faculty co-chair OncoMenopause and the OncoMenopause Consortium® programming and bring frontline clinical experience treating breast cancer survivors.
-
Lisa C. Larkin, MD, FACP, MSCP, IF
FOUNDER & EXECUTIVE DIRECTOR
HERmedicine & OncoMenopause Consortium
-
Maryam Lustberg, MD, MPH
DIRECTOR, YALE BREAST CENTER
Chief, Breast Oncology, Yale School of Medicine
WHAT YOU’LL LEAVE WITH
Four things you can use the next week in clinic
Practical frameworks
Real cases and hard questions — not a theoretical review.
Where evidence ends
What the data shows, what it doesn't, and where nuance is required.
The modern landscape
Hormonal and newer targeted nonhormonal options, and how they fit.
A team approach
Menopause, oncology, breast health, GYN, and sexual medicine together.
THE PROGRAM
What's on the Agenda?
Early-bird registration ($275) opens soon — $325 general registration after early-bird closes.
Final faculty to be confirmed.
LOGISTICS
What to know before you go?
FREQUENTLY ASKED QUESTIONS
What Clinicians Ask Before They Register
-
It's rarely a simple yes or no. This program teaches clinicians the evidence, the nuance, and the practical frameworks for evaluating it case by case in breast cancer survivors.
-
Women's health clinicians across specialties — including oncology, gynecology, internal medicine, and endocrinology — who manage menopause symptoms in patients with a history of breast cancer.
-
4.5 AMA PRA Category 1 Credits™, earned across a lecture, three case panels, and a live Q&A.
-
Yes. Breakfast is served from 7:00 to 7:45 AM before the CME sessions begin.
-
Omni San Diego, Hotel at the Ballpark, on Tuesday, October 20, 2026, the morning before The Menopause Society Annual Meeting begins.
-
Dr. Lisa Larkin, Founder & Executive Director of HERmedicine & OncoMenopause Consortium, and Dr. Maryam Lustberg, Director of the Yale Breast Center and Chief of Breast Oncology at Yale School of Medicine.
GET EARLY-BIRD ALERTS
Seats are limited to keep the case discussions clinically useful
Join Dr. Larkin and Dr. Lustberg for a morning built around real decisions — get notified the moment early-bird registration opens for the Omni San Diego program.
$275 early-bird · $325 general registration · 4.5 AMA PRA Category 1 Credits™ · Breakfast included
No separate trip. No extra day off. Make the most of San Diego.